US Stock MarketDetailed Quotes

NRBO NeuroBo Pharmaceuticals

Watchlist
  • 4.2400
  • +0.1300+3.16%
Close May 15 16:00 ET
  • 4.2400
  • 0.00000.00%
Post 19:11 ET
20.80MMarket Cap-1296P/E (TTM)

NeuroBo Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
173.06%6.88M
39.13%15.89M
155.27%5.67M
25.42%3.89M
18.24%3.81M
-12.35%2.52M
-25.36%11.42M
-51.51%2.22M
-10.39%3.1M
-18.01%3.22M
Selling and administrative expenses
4.99%1.98M
-22.13%6.73M
-5.90%1.8M
-36.79%1.6M
-35.54%1.44M
-3.68%1.88M
-1.28%8.64M
-25.80%1.92M
22.37%2.53M
16.88%2.24M
-General and administrative expense
4.99%1.98M
-22.13%6.73M
-5.90%1.8M
-36.79%1.6M
-35.54%1.44M
-3.68%1.88M
-1.28%8.64M
-25.80%1.92M
22.37%2.53M
16.88%2.24M
Research and development costs
669.86%4.9M
229.66%9.16M
1,167.21%3.87M
301.40%2.29M
140.73%2.36M
-30.76%637K
-57.56%2.78M
-84.73%305K
-59.04%571K
-51.19%982K
Operating profit
-173.06%-6.88M
-39.13%-15.89M
-155.27%-5.67M
-25.42%-3.89M
-18.24%-3.81M
12.35%-2.52M
25.36%-11.42M
51.51%-2.22M
10.39%-3.1M
18.01%-3.22M
Net non-operating interest income expense
237K
121.04%461K
113.65%299K
162K
0
-15,750.00%-2.19M
-2.19M
0
Non-operating interest income
--237K
--461K
--299K
--162K
----
--0
--0
--0
--0
----
Non-operating interest expense
----
--0
----
----
----
----
--2.19M
----
----
----
Other net income (expense)
16.67%-70K
925.42%2.96M
120.38%54K
-866.67%-87K
3,757.14%3.07M
-84K
-358K
-265K
-9K
-84K
Gain on sale of security
16.67%-70K
-62.76%2.96M
--54K
---87K
--3.07M
---84K
--7.94M
----
----
----
Special income (charges)
----
--0
----
----
----
----
---8.21M
----
----
----
-Less:Other special charges
----
----
----
----
----
----
--8.21M
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
----
---83K
--10K
---9K
---84K
Income before tax
-157.83%-6.71M
10.72%-12.47M
-13.64%-5.31M
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-157.83%-6.71M
10.72%-12.47M
-13.64%-5.31M
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
Net income continuous Operations
-157.83%-6.71M
10.72%-12.47M
-13.64%-5.31M
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
Minority interest income
Net income attributable to the parent company
-157.83%-6.71M
10.72%-12.47M
-13.64%-5.31M
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-157.83%-6.71M
10.72%-12.47M
-13.64%-5.31M
-22.65%-3.82M
77.78%-734K
9.43%-2.6M
8.62%-13.97M
-2.14%-4.68M
10.05%-3.11M
15.76%-3.3M
Basic earnings per share
67.65%-1.32
94.33%-2.46
30.64%-1.02
97.43%-0.72
99.46%-0.16
84.26%-4.08
72.60%-43.42
96.49%-1.4707
24.89%-28
31.11%-29.76
Diluted earnings per share
67.65%-1.32
94.33%-2.46
30.64%-1.02
97.43%-0.72
99.46%-0.16
84.26%-4.08
72.60%-43.42
96.49%-1.4707
24.89%-28
31.11%-29.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 173.06%6.88M39.13%15.89M155.27%5.67M25.42%3.89M18.24%3.81M-12.35%2.52M-25.36%11.42M-51.51%2.22M-10.39%3.1M-18.01%3.22M
Selling and administrative expenses 4.99%1.98M-22.13%6.73M-5.90%1.8M-36.79%1.6M-35.54%1.44M-3.68%1.88M-1.28%8.64M-25.80%1.92M22.37%2.53M16.88%2.24M
-General and administrative expense 4.99%1.98M-22.13%6.73M-5.90%1.8M-36.79%1.6M-35.54%1.44M-3.68%1.88M-1.28%8.64M-25.80%1.92M22.37%2.53M16.88%2.24M
Research and development costs 669.86%4.9M229.66%9.16M1,167.21%3.87M301.40%2.29M140.73%2.36M-30.76%637K-57.56%2.78M-84.73%305K-59.04%571K-51.19%982K
Operating profit -173.06%-6.88M-39.13%-15.89M-155.27%-5.67M-25.42%-3.89M-18.24%-3.81M12.35%-2.52M25.36%-11.42M51.51%-2.22M10.39%-3.1M18.01%-3.22M
Net non-operating interest income expense 237K121.04%461K113.65%299K162K0-15,750.00%-2.19M-2.19M0
Non-operating interest income --237K--461K--299K--162K------0--0--0--0----
Non-operating interest expense ------0------------------2.19M------------
Other net income (expense) 16.67%-70K925.42%2.96M120.38%54K-866.67%-87K3,757.14%3.07M-84K-358K-265K-9K-84K
Gain on sale of security 16.67%-70K-62.76%2.96M--54K---87K--3.07M---84K--7.94M------------
Special income (charges) ------0-------------------8.21M------------
-Less:Other special charges --------------------------8.21M------------
Other non- operating income (expenses) ---------------------------83K--10K---9K---84K
Income before tax -157.83%-6.71M10.72%-12.47M-13.64%-5.31M-22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M
Income tax 0000000000
Net income -157.83%-6.71M10.72%-12.47M-13.64%-5.31M-22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M
Net income continuous Operations -157.83%-6.71M10.72%-12.47M-13.64%-5.31M-22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M
Minority interest income
Net income attributable to the parent company -157.83%-6.71M10.72%-12.47M-13.64%-5.31M-22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -157.83%-6.71M10.72%-12.47M-13.64%-5.31M-22.65%-3.82M77.78%-734K9.43%-2.6M8.62%-13.97M-2.14%-4.68M10.05%-3.11M15.76%-3.3M
Basic earnings per share 67.65%-1.3294.33%-2.4630.64%-1.0297.43%-0.7299.46%-0.1684.26%-4.0872.60%-43.4296.49%-1.470724.89%-2831.11%-29.76
Diluted earnings per share 67.65%-1.3294.33%-2.4630.64%-1.0297.43%-0.7299.46%-0.1684.26%-4.0872.60%-43.4296.49%-1.470724.89%-2831.11%-29.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg